Search

Eli Lilly and Company - search results

If you're not happy with the results, please do another search

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to...

Scivita Medical Technology Co., Ltd. ("civita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become...
Lilly

Global Healthcare Firm Eli Lilly Completes Acquisition of Prevail Therapeutics

NEW YORK, USA - NYSE-listed Eli Lilly and Company announced the successful completion of its acquisition of gene therapies firm Prevail Therapeutics. The acquisition establishes...

Junshi Biosciences Announces Financial Results for Six Months Ended June 30, 2020 and Provides...

-- Supplemental NDAs for Toripalimab filed -- Expanding into infectious disease and collaborating with IMCAS and Lilly for COVID-19 neutralizing antibodies -- Dual Listing on the...
Covid-19

Lilly Now in Phase 3 Clinical Trial for Covid-19 Drug Baricitinib

New York-listed Eli Lilly and Company announced today that the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled study to...
Covid-19

Lilly Starts World’s First Study of Potential Covid-19 Antibody Treatment in Humans

Healthcare firm Eli Lilly and Company announced that it has began the world’s first study of potential Covid-19 antibody treatment's in human by dosing...

Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies

CB6 demonstrated prophylactic and treatment effects in rhesus monkeys Clinical testing expected to begin in second quarter in collaboration with Eli Lilly and...

Legend Capital Led a New Round of Investment of Etana

Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKG: 1801), and a...

Legend Capital leads ForQaly Medical’s Series B financing

ForQaly Medical (hereinafter referred to as ForQaly), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing micro-traumatic circulatory...

China Medical System Holdings Ltd. (0867. HK) Strategically Introduces Overseas Launched Blockbuster Innovative Products

On June 27, 2019, China Medical System Holdings Ltd. ("China Medical System" or the "Company") announced that the Company introduced Tildrakizumab, a product used...

Innovent HK IPO gains wide support from international investors; Spearheads in cancer treatment breakthroughs

HONG KONG - (ACN Newswire) - Chinese biologic drug developer Innovent Biologics (Innovent) becomes the 4th pre-revenue biotech firm to list in Hong Kong yesterday. The seven-year-old...